189 related articles for article (PubMed ID: 36239783)
1. Transcutaneous electrical acupoint stimulation for suspected laryngopharyngeal reflux disease.
Shen H; Han Y; Yao C; Tao Y; Wu J; Gao C; Wu F; Liu Y
Eur Arch Otorhinolaryngol; 2023 Apr; 280(4):1815-1825. PubMed ID: 36239783
[TBL] [Abstract][Full Text] [Related]
2. Trial of transcutaneous electrical acupoint stimulation in laryngopharyngeal reflux disease: study protocol for a randomized controlled trial.
Shen H; Han Y; Wu D; Hu L; Ma Y; Wu F; Tao Y; Liu Y
Trials; 2022 Apr; 23(1):272. PubMed ID: 35395946
[TBL] [Abstract][Full Text] [Related]
3. [Effect of proton pump inhibitort on salivary pepsin concentration in patients with laryngopharyngeal reflux].
Zhang Q; Xie M; Guo R; Ma S; Liu X; Yang M; Li N; Liu H; Ren X; Luo H
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Nov; 35(11):965-970. PubMed ID: 34886597
[No Abstract] [Full Text] [Related]
4. Relationship between extralaryngeal endoscopic findings, proton pump inhibitor (PPI) response, and pH measures in suspected laryngopharyngeal reflux.
Agrawal N; Yadlapati R; Shabeeb N; Price CP; Lidder A; Shintani-Smith S; Bové M; Pandolfino J; Tan B
Dis Esophagus; 2019 Apr; 32(4):. PubMed ID: 30101358
[TBL] [Abstract][Full Text] [Related]
5. Influence of age on treatment with proton pump inhibitors in patients with laryngopharyngeal reflux disease: a prospective multicenter study.
Lee YC; Lee JS; Kim SW; Kwon KH; Eun YG
JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1291-5. PubMed ID: 24201320
[TBL] [Abstract][Full Text] [Related]
6. [Correlation analysis between Dx-pH monitoring and proton pump inhibitor test in the diagnosis of laryngopharyngeal reflux disease].
Chen ZL; Wu HW; Mei XW; Yin WH; Xu SY; Liu SQ; Chen YC; Wang G; Zhang CJ; Ding XL; Wu JN
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Jan; 55(1):34-39. PubMed ID: 31954386
[No Abstract] [Full Text] [Related]
7. Magnesium alginate versus proton pump inhibitors for the treatment of laryngopharyngeal reflux: a non-inferiority randomized controlled trial.
Pizzorni N; Ambrogi F; Eplite A; Rama S; Robotti C; Lechien J; Schindler A
Eur Arch Otorhinolaryngol; 2022 May; 279(5):2533-2542. PubMed ID: 35032204
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of three proton-pump inhibitor therapeutic strategies on laryngopharyngeal reflux disease; a prospective randomized double-blind study.
Yoon YH; Park KW; Lee SH; Park HS; Chang JW; Koo BS
Clin Otolaryngol; 2019 Jul; 44(4):612-618. PubMed ID: 31002475
[TBL] [Abstract][Full Text] [Related]
9. Weaning of proton pump inhibitors in patients with suspected laryngopharyngeal reflux disease.
Lin RJ; Sridharan S; Smith LJ; Young VN; Rosen CA
Laryngoscope; 2018 Jan; 128(1):133-137. PubMed ID: 28730666
[TBL] [Abstract][Full Text] [Related]
10. Nissen fundoplication
Zhang C; Hu ZW; Yan C; Wu Q; Wu JM; Du X; Liu DG; Luo T; Li F; Wang ZG
World J Gastroenterol; 2017 May; 23(19):3546-3555. PubMed ID: 28596691
[TBL] [Abstract][Full Text] [Related]
11. The Use of Inhaled N-Acetylcysteine for Laryngopharyngeal Reflux Disease: A Randomized Controlled Trial.
Jo YS; Choi IS; So YK
J Voice; 2021 Jul; 35(4):618-624. PubMed ID: 31848062
[TBL] [Abstract][Full Text] [Related]
12. A Prospective Randomized Clinical Trial of Combination Therapy with Proton Pump Inhibitors and Mucolytics in Patients with Laryngopharyngeal Reflux.
Chae M; Jang DH; Kim HC; Kwon M
Ann Otol Rhinol Laryngol; 2020 Aug; 129(8):781-787. PubMed ID: 32186395
[TBL] [Abstract][Full Text] [Related]
13. Changes in the quality of life of patients with laryngopharyngeal reflux after treatment.
Lee JS; Lee YC; Kim SW; Kwon KH; Eun YG
J Voice; 2014 Jul; 28(4):487-91. PubMed ID: 24598356
[TBL] [Abstract][Full Text] [Related]
14. LPR: how different diagnostic tools shape the outcomes of treatment.
Wan Y; Yan Y; Ma F; Wang L; Lu P; Maytag A; Jiang JJ
J Voice; 2014 May; 28(3):362-8. PubMed ID: 24491501
[TBL] [Abstract][Full Text] [Related]
15. How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related?
de Bortoli N; Nacci A; Savarino E; Martinucci I; Bellini M; Fattori B; Ceccarelli L; Costa F; Mumolo MG; Ricchiuti A; Savarino V; Berrettini S; Marchi S
World J Gastroenterol; 2012 Aug; 18(32):4363-70. PubMed ID: 22969200
[TBL] [Abstract][Full Text] [Related]
16. Reflux finding score and reflux symptom index as potential predictors for proton pump inhibitor response in globus pharyngeus patients: A prospective study.
Boom L; Edens M; Rinia B
Auris Nasus Larynx; 2020 Aug; 47(4):609-615. PubMed ID: 32113831
[TBL] [Abstract][Full Text] [Related]
17. Upper Esophageal Sphincter Compression Device as an Adjunct to Proton Pump Inhibition for Laryngopharyngeal Reflux.
Yadlapati R; Pandolfino JE; Greytak M; Cahoon J; Clarke M; Clary M; Fink D; Menard-Katcher P; Vahabzadeh-Hagh AM; Weissbrod P; Gupta S; Kaizer A; Wani S
Dig Dis Sci; 2022 Jul; 67(7):3045-3054. PubMed ID: 34275061
[TBL] [Abstract][Full Text] [Related]
18. Proton Pump Inhibitor Ameliorates Taste Disturbance among Patients with Laryngopharyngeal Reflux: A Randomized Controlled Study.
Suzuki M; Yokota M; Matsumoto T; Nakayama M; Takemura M; Kanemitsu Y; Niimi A; Nakamura Y; Murakami S
Tohoku J Exp Med; 2019 Jan; 247(1):19-25. PubMed ID: 30643081
[TBL] [Abstract][Full Text] [Related]
19. Vocal Tract Discomfort and Dysphonia in Patients Undergoing Empiric Therapeutic Trial with Proton Pump Inhibitor for Suspected Laryngopharyngeal Reflux.
Mozzanica F; Robotti C; Lechien JR; Pizzorni N; Pirola F; Mengucci A; Dell'Era A; Ottaviani F; Schindler A
J Voice; 2020 Mar; 34(2):280-288. PubMed ID: 30563730
[TBL] [Abstract][Full Text] [Related]
20. Saliva Pepsin Detection and Proton Pump Inhibitor Response in Suspected Laryngopharyngeal Reflux.
Wang CP; Wang CC; Lien HC; Lin WJ; Wu SH; Liang KL; Liu SA
Laryngoscope; 2019 Mar; 129(3):709-714. PubMed ID: 30247754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
